Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration
Articolo
Data di Pubblicazione:
2014
Citazione:
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration / Lorenzo, Moja; Ersilia, Lucenteforte; Koren H., Kwag; Vittorio, Bertele; Annalisa, Campomori; Usha, Chakravarthy; D'Amico, Roberto; Kay, Dickersin; Laurent, Kodjikian; Kristina, Lindsley; Yoon, Loke; Maureen, Maguire; Daniel F., Martin; Alessandro, Mugelli; Bernd, Mühlbauer; Isabel, Püntmann; Barnaby, Reeves; Chris, Rogers; Christine, Schmucker; Manju L., Subramanian; Gianni, Virgili. - In: COCHRANE DATABASE OF SYSTEMATIC REVIEWS. - ISSN 1469-493X. - 2014:9(2014), pp. 1-58. [10.1002/14651858.CD011230.pub2]
Abstract:
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the systemic safety of intravitreal bevacizumab compared with intravitreal ranibizumab in people with neovascular AMD.
Tipologia CRIS:
Articolo su rivista
Keywords:
Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Humans; Intravitreal Injections; Macular Degeneration; Middle Aged; Ranibizumab; Vascular Endothelial Growth Factor A
Elenco autori:
Lorenzo, Moja; Ersilia, Lucenteforte; Koren H., Kwag; Vittorio, Bertele; Annalisa, Campomori; Usha, Chakravarthy; D'Amico, Roberto; Kay, Dickersin; Laurent, Kodjikian; Kristina, Lindsley; Yoon, Loke; Maureen, Maguire; Daniel F., Martin; Alessandro, Mugelli; Bernd, Mühlbauer; Isabel, Püntmann; Barnaby, Reeves; Chris, Rogers; Christine, Schmucker; Manju L., Subramanian; Gianni, Virgili
Link alla scheda completa:
Pubblicato in: